UNIVERSAL TECHNICAL INSTITUT (UTI) Stock Fundamental Analysis
USA - NYSE:UTI - US9139151040 - Common Stock
28.32 USD
-1.13 (-3.84%)
28.32 USD
0 (0%)
UTI gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 79 industry peers in the Diversified Consumer Services industry. UTI scores excellent on profitability, but there are some minor concerns on its financial health. UTI is growing strongly while it is still valued neutral. This is a good combination! These ratings would make UTI suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year UTI was profitable.
In the past year UTI had a positive cash flow from operations.
UTI had positive earnings in each of the past 5 years.
In the past 5 years UTI always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 8.52%, UTI is doing good in the industry, outperforming 75.95% of the companies in the same industry.
With an excellent Return On Equity value of 20.57%, UTI belongs to the best of the industry, outperforming 84.81% of the companies in the same industry.
With an excellent Return On Invested Capital value of 10.86%, UTI belongs to the best of the industry, outperforming 81.01% of the companies in the same industry.
UTI had an Average Return On Invested Capital over the past 3 years of 5.11%. This is below the industry average of 10.05%.
The last Return On Invested Capital (10.86%) for UTI is above the 3 year average (5.11%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.52% | ||
| ROE | 20.57% | ||
| ROIC | 10.86% |
ROA(3y)2.68%
ROA(5y)2.09%
ROE(3y)7.52%
ROE(5y)5.81%
ROIC(3y)5.11%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 7.79%, UTI is in the better half of the industry, outperforming 68.35% of the companies in the same industry.
In the last couple of years the Profit Margin of UTI has grown nicely.
UTI has a better Operating Margin (10.44%) than 67.09% of its industry peers.
In the last couple of years the Operating Margin of UTI has grown nicely.
Looking at the Gross Margin, with a value of 49.65%, UTI is in line with its industry, outperforming 53.16% of the companies in the same industry.
UTI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.44% | ||
| PM (TTM) | 7.79% | ||
| GM | 49.65% |
OM growth 3Y21.82%
OM growth 5YN/A
PM growth 3Y23.23%
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-8.67%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UTI is creating some value.
UTI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for UTI has been increased compared to 5 years ago.
The debt/assets ratio for UTI has been reduced compared to a year ago.
2.2 Solvency
UTI has an Altman-Z score of 3.84. This indicates that UTI is financially healthy and has little risk of bankruptcy at the moment.
UTI has a better Altman-Z score (3.84) than 83.54% of its industry peers.
UTI has a debt to FCF ratio of 0.99. This is a very positive value and a sign of high solvency as it would only need 0.99 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.99, UTI belongs to the best of the industry, outperforming 83.54% of the companies in the same industry.
UTI has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.23, UTI is in line with its industry, outperforming 55.70% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 0.99 | ||
| Altman-Z | 3.84 |
ROIC/WACC1.27
WACC8.54%
2.3 Liquidity
A Current Ratio of 1.00 indicates that UTI should not have too much problems paying its short term obligations.
UTI's Current ratio of 1.00 is in line compared to the rest of the industry. UTI outperforms 41.77% of its industry peers.
UTI has a Quick Ratio of 1.00. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.00, UTI is in line with its industry, outperforming 46.84% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
UTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 128.00%, which is quite impressive.
The Earnings Per Share has been growing by 28.35% on average over the past years. This is a very strong growth
Looking at the last year, UTI shows a quite strong growth in Revenue. The Revenue has grown by 14.56% in the last year.
UTI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.19% yearly.
EPS 1Y (TTM)128%
EPS 3Y28.35%
EPS 5YN/A
EPS Q2Q%111.11%
Revenue 1Y (TTM)14.56%
Revenue growth 3Y29.79%
Revenue growth 5Y17.19%
Sales Q2Q%15.12%
3.2 Future
Based on estimates for the next years, UTI will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.50% on average per year.
Based on estimates for the next years, UTI will show a quite strong growth in Revenue. The Revenue will grow by 10.46% on average per year.
EPS Next Y44.42%
EPS Next 2Y12.22%
EPS Next 3Y12.5%
EPS Next 5YN/A
Revenue Next Year14.42%
Revenue Next 2Y11.29%
Revenue Next 3Y10.46%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 24.84, UTI is valued on the expensive side.
UTI's Price/Earnings ratio is in line with the industry average.
UTI is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.56, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 30.39, the valuation of UTI can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UTI is on the same level as its industry peers.
UTI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 34.62.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.84 | ||
| Fwd PE | 30.39 |
4.2 Price Multiples
UTI's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, UTI is valued a bit cheaper than 64.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.62 | ||
| EV/EBITDA | 12.38 |
4.3 Compensation for Growth
UTI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
UTI has a very decent profitability rating, which may justify a higher PE ratio.
UTI's earnings are expected to grow with 12.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.56
PEG (5Y)N/A
EPS Next 2Y12.22%
EPS Next 3Y12.5%
5. Dividend
5.1 Amount
No dividends for UTI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
28.32
-1.13 (-3.84%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners94.48%
Inst Owner Change0.5%
Ins Owners2.24%
Ins Owner Change0.78%
Market Cap1.54B
Revenue(TTM)809.53M
Net Income(TTM)63.10M
Analysts81.82
Price Target38.18 (34.82%)
Short Float %3.62%
Short Ratio2.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.03
Dividend Growth(5Y)-34.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.27%
Min EPS beat(2)69.26%
Max EPS beat(2)73.27%
EPS beat(4)4
Avg EPS beat(4)69.47%
Min EPS beat(4)12.21%
Max EPS beat(4)123.12%
EPS beat(8)7
Avg EPS beat(8)80.23%
EPS beat(12)10
Avg EPS beat(12)129.78%
EPS beat(16)14
Avg EPS beat(16)215.22%
Revenue beat(2)2
Avg Revenue beat(2)2.83%
Min Revenue beat(2)1.15%
Max Revenue beat(2)4.51%
Revenue beat(4)4
Avg Revenue beat(4)2.54%
Min Revenue beat(4)1.15%
Max Revenue beat(4)4.51%
Revenue beat(8)8
Avg Revenue beat(8)2.39%
Revenue beat(12)11
Avg Revenue beat(12)2.98%
Revenue beat(16)15
Avg Revenue beat(16)3.43%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.02%
EPS NY rev (1m)-0.31%
EPS NY rev (3m)1.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.84 | ||
| Fwd PE | 30.39 | ||
| P/S | 1.9 | ||
| P/FCF | 20.62 | ||
| P/OCF | 14.3 | ||
| P/B | 5.02 | ||
| P/tB | 5.91 | ||
| EV/EBITDA | 12.38 |
EPS(TTM)1.14
EY4.03%
EPS(NY)0.93
Fwd EY3.29%
FCF(TTM)1.37
FCFY4.85%
OCF(TTM)1.98
OCFY6.99%
SpS14.88
BVpS5.64
TBVpS4.79
PEG (NY)0.56
PEG (5Y)N/A
Graham Number12.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.52% | ||
| ROE | 20.57% | ||
| ROCE | 15.21% | ||
| ROIC | 10.86% | ||
| ROICexc | 13.78% | ||
| ROICexgc | 15.4% | ||
| OM | 10.44% | ||
| PM (TTM) | 7.79% | ||
| GM | 49.65% | ||
| FCFM | 9.23% |
ROA(3y)2.68%
ROA(5y)2.09%
ROE(3y)7.52%
ROE(5y)5.81%
ROIC(3y)5.11%
ROIC(5y)N/A
ROICexc(3y)7.05%
ROICexc(5y)N/A
ROICexgc(3y)7.97%
ROICexgc(5y)N/A
ROCE(3y)7.15%
ROCE(5y)N/A
ROICexgc growth 3Y41.64%
ROICexgc growth 5YN/A
ROICexc growth 3Y37.09%
ROICexc growth 5YN/A
OM growth 3Y21.82%
OM growth 5YN/A
PM growth 3Y23.23%
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-8.67%
F-Score6
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 0.99 | ||
| Debt/EBITDA | 0.58 | ||
| Cap/Depr | 87.82% | ||
| Cap/Sales | 4.08% | ||
| Interest Coverage | 11.6 | ||
| Cash Conversion | 88.25% | ||
| Profit Quality | 118.43% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.84 |
F-Score6
WACC8.54%
ROIC/WACC1.27
Cap/Depr(3y)259.47%
Cap/Depr(5y)259.17%
Cap/Sales(3y)10.54%
Cap/Sales(5y)10.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)128%
EPS 3Y28.35%
EPS 5YN/A
EPS Q2Q%111.11%
EPS Next Y44.42%
EPS Next 2Y12.22%
EPS Next 3Y12.5%
EPS Next 5YN/A
Revenue 1Y (TTM)14.56%
Revenue growth 3Y29.79%
Revenue growth 5Y17.19%
Sales Q2Q%15.12%
Revenue Next Year14.42%
Revenue Next 2Y11.29%
Revenue Next 3Y10.46%
Revenue Next 5YN/A
EBIT growth 1Y85.69%
EBIT growth 3Y58.11%
EBIT growth 5YN/A
EBIT Next Year114.2%
EBIT Next 3Y30.39%
EBIT Next 5YN/A
FCF growth 1Y395.38%
FCF growth 3YN/A
FCF growth 5Y32.12%
OCF growth 1Y222.73%
OCF growth 3Y15.89%
OCF growth 5Y31.61%
UNIVERSAL TECHNICAL INSTITUT / UTI FAQ
What is the fundamental rating for UTI stock?
ChartMill assigns a fundamental rating of 6 / 10 to UTI.
Can you provide the valuation status for UNIVERSAL TECHNICAL INSTITUT?
ChartMill assigns a valuation rating of 4 / 10 to UNIVERSAL TECHNICAL INSTITUT (UTI). This can be considered as Fairly Valued.
Can you provide the profitability details for UNIVERSAL TECHNICAL INSTITUT?
UNIVERSAL TECHNICAL INSTITUT (UTI) has a profitability rating of 7 / 10.
What are the PE and PB ratios of UNIVERSAL TECHNICAL INSTITUT (UTI) stock?
The Price/Earnings (PE) ratio for UNIVERSAL TECHNICAL INSTITUT (UTI) is 24.84 and the Price/Book (PB) ratio is 5.02.
Can you provide the expected EPS growth for UTI stock?
The Earnings per Share (EPS) of UNIVERSAL TECHNICAL INSTITUT (UTI) is expected to grow by 44.42% in the next year.